Shares of Reckitt Benckiser Group plc (LON:RKT – Get Free Report) have been assigned a consensus rating of “Hold” from the seven research firms that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is GBX 6,279.29.
RKT has been the subject of a number of recent research reports. Citigroup began coverage on Reckitt Benckiser Group in a report on Wednesday, January 14th. They set a “buy” rating and a GBX 7,000 price objective for the company. Jefferies Financial Group upped their target price on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a “hold” rating in a research note on Wednesday, January 7th. JPMorgan Chase & Co. raised their price target on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the company a “neutral” rating in a research report on Wednesday, November 26th. Finally, Royal Bank Of Canada cut shares of Reckitt Benckiser Group to a “sector perform” rating and cut their price target for the stock from GBX 6,400 to GBX 6,200 in a report on Wednesday, January 14th.
View Our Latest Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 2.1%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its earnings results on Thursday, March 5th. The company reported £122.58 EPS for the quarter. Reckitt Benckiser Group had a net margin of 25.23% and a return on equity of 38.45%. On average, equities research analysts predict that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
